PART I - FINANCIAL INFORMATION Condensed Consolidated Financial Statements Presents unaudited condensed consolidated financial statements, with total assets at $1.46 billion and six-month revenues of $435.4 million Condensed Consolidated Balance Sheets Total assets increased to $1.46 billion from $1.37 billion, with liabilities reaching $1.0 billion and equity at $439.7 million Key Balance Sheet Items (in thousands) | Balance Sheet Item | June 30, 2020 (Unaudited) | December 31, 2019 | | :--- | :--- | :--- | | Total current assets | $422,426 | $425,192 | | Energy assets, net | $637,618 | $579,461 | | Total assets | $1,459,532 | $1,374,013 | | Total current liabilities | $272,978 | $336,647 | | Long-term debt and financing lease liabilities | $295,048 | $266,181 | | Total liabilities | $983,556 | $912,541 | | Total stockholders' equity | $439,673 | $428,856 | Condensed Consolidated Statements of Income Q2 revenues rose to $223.0 million, but net income attributable to common shareholders decreased to $4.4 million Statements of Income Highlights (in thousands, except per share data) | Metric | Q2 2020 | Q2 2019 | Six Months 2020 | Six Months 2019 | | :--- | :--- | :--- | :--- | :--- | | Revenues | $223,036 | $198,183 | $435,449 | $348,295 | | Gross Profit | $39,508 | $43,139 | $77,954 | $75,771 | | Operating Income | $12,888 | $13,057 | $22,410 | $19,606 | | Net Income | $8,836 | $8,507 | $15,472 | $11,378 | | Net Income Attributable to Common Shareholders | $4,365 | $9,216 | $10,566 | $13,363 | | Diluted EPS | $0.09 | $0.19 | $0.22 | $0.28 | Condensed Consolidated Statements of Cash Flows Net cash used in operating activities improved to $73.6 million, while financing activities provided $142.4 million for the six-month period Cash Flow Summary (in thousands) | Cash Flow Activity | Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | | :--- | :--- | :--- | | Net cash from operating activities | $(73,594) | $(109,254) | | Net cash from investing activities | $(78,700) | $(50,746) | | Net cash from financing activities | $142,406 | $135,663 | | Net decrease in cash | $(10,345) | $(24,237) | Notes to Condensed Consolidated Financial Statements (Unaudited) Provides detailed disclosures on accounting policies, revenue recognition, and debt, noting no material COVID-19 impact and CARES Act benefits - The company's backlog of remaining performance obligations was approximately $2.15 billion as of June 30, 2020, with about 27% expected to be recognized as revenue in the next twelve months37 - The company adopted new accounting standards for credit losses (ASU 2016-13) and fair value measurement (ASU 2018-13) as of January 1, 2020, with no material impact on its financial statements2325 - The CARES Act, enacted in March 2020, allows the company to delay approximately $5.0 million of employer payroll taxes and is estimated to provide a discrete tax benefit of about $2.0 million from net operating loss carryback provisions19 Management's Discussion and Analysis of Financial Condition and Results of Operations Discusses Q2 and H1 2020 financial results, highlighting a 25% revenue increase to $435.4 million and strong backlog Results of Operations Six-month revenues increased 25.0% to $435.4 million, while gross margin declined to 17.9% due to project mix Six Months Ended June 30, 2020 vs 2019 (in millions) | Metric | H1 2020 | H1 2019 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Revenues | $435.4 | $348.3 | $87.1 | 25.0% | | Gross Profit | $78.0 | $75.8 | $2.2 | 2.9% | | Gross Margin | 17.9% | 21.8% | - | -3.9 p.p. | | SG&A Expenses | $55.5 | $56.2 | $(0.7) | (1.1)% | | Operating Income | $22.4 | $19.6 | $2.8 | 14.3% | - The decrease in gross margin for both the three and six-month periods was primarily attributed to an increased level of design-build work and other lower-margin projects within the revenue mix126 - The company recorded a tax benefit of $2.5 million for H1 2020, compared to a $1.1 million provision in H1 2019, mainly due to investment tax credits and benefits from the CARES Act's net operating loss carryback provisions131 Backlog and Awarded Projects Fully-contracted backlog increased to $1.02 billion, with awarded projects at $1.20 billion, indicating a robust pipeline Backlog and Pipeline Comparison (in millions) | Metric | June 30, 2020 | June 30, 2019 | | :--- | :--- | :--- | | Fully-Contracted Backlog | $1,017.7 | $788.7 | | Awarded Projects | $1,201.9 | $1,236.5 | | O&M Backlog | $1,133.5 | $906.5 | | Assets in Development | $752.5 | $518.4 | Business Segment Analysis U.S. Federal segment revenue grew 56.2% to $153.2 million, leading overall segment growth, while 'All Other' declined - The U.S. Federal segment revenue grew by 56.2% to $153.2 million for the six months ended June 30, 2020, due to the timing and phase of active projects138139 - The U.S. Regions segment revenue increased by 20.6% to $173.4 million for the first half of 2020, also driven by the timing of project revenue recognition136 - The 'All Other' segment's revenue decreased by 9.3% in H1 2020, primarily due to a decline in integrated PV revenues145 Liquidity and Capital Resources Liquidity is funded by operations and debt, with $73.6 million used in operations and $142.4 million provided by financing - The company plans to invest approximately $110.0 million to $160.0 million in additional capital expenditures for the remainder of 2020, principally for the construction or acquisition of new renewable energy plants150151 - The CARES Act is expected to improve liquidity by allowing the delay of approximately $5.0 million in 2020 employer payroll taxes and providing tax refunds of approximately $5.3 million related to net operating loss carrybacks and Alternative Minimum Tax credits150 - In June 2020, the company entered into a new $100 million revolving credit agreement to finance construction costs of its owned projects108 Quantitative and Qualitative Disclosures About Market Risk No significant changes in market risk exposures were reported as of June 30, 2020, compared to prior disclosures - There were no significant changes in market risk exposures as of June 30, 2020, compared to those disclosed in the company's 2019 Annual Report153 Controls and Procedures Management concluded disclosure controls and procedures were effective, with no material changes in internal control over financial reporting - Management concluded that the company's disclosure controls and procedures were effective as of the end of the period covered by this report154155 - No changes in internal control over financial reporting occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, internal controls155 PART II - OTHER INFORMATION Legal Proceedings The company does not anticipate any material adverse effects from current legal proceedings on its financial condition - The company states that it does not expect any currently pending legal proceedings to have a material adverse effect on its business, results of operations, or financial condition157 Risk Factors No material changes to the company's previously disclosed risk factors were reported as of June 30, 2020 - No material changes to the company's risk factors were reported as of June 30, 2020158 Unregistered Sales of Equity Securities and Use of Proceeds No shares were repurchased under the stock repurchase program in Q2 2020, with $5.9 million remaining available Stock Repurchase Program Activity (Q2 2020) | Period | Total Shares Purchased | Average Price Paid | Approx. Dollar Value Remaining ($) | | :--- | :--- | :--- | :--- | | Q2 2020 | 0 | $0 | $5,897,229 | Exhibits Lists exhibits filed with the Quarterly Report on Form 10-Q, including officer certifications and XBRL financial data
Ameresco(AMRC) - 2020 Q2 - Quarterly Report